Cargando…

Recent advances in perinatal neuroprotection

Perinatal brain injury is a major cause of neurological disability in both premature and term infants. In this review, we summarize the evidence behind some established neuroprotective practices such as administration of antenatal steroids, intrapartum magnesium for preterm delivery, and therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhi, Samata, Johnston, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979470/
https://www.ncbi.nlm.nih.gov/pubmed/32047595
http://dx.doi.org/10.12688/f1000research.20722.1
_version_ 1783490903686512640
author Singhi, Samata
Johnston, Michael
author_facet Singhi, Samata
Johnston, Michael
author_sort Singhi, Samata
collection PubMed
description Perinatal brain injury is a major cause of neurological disability in both premature and term infants. In this review, we summarize the evidence behind some established neuroprotective practices such as administration of antenatal steroids, intrapartum magnesium for preterm delivery, and therapeutic hypothermia. In addition, we examine emerging practices such as delayed cord clamping, postnatal magnesium administration, recombinant erythropoietin, and non-steroidal anti-inflammatory agents and finally inform the reader about novel interventions, some of which are currently in trials, such as xenon, melatonin, topiramate, allopurinol, creatine, and autologous cord cell therapy.
format Online
Article
Text
id pubmed-6979470
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-69794702020-02-10 Recent advances in perinatal neuroprotection Singhi, Samata Johnston, Michael F1000Res Review Perinatal brain injury is a major cause of neurological disability in both premature and term infants. In this review, we summarize the evidence behind some established neuroprotective practices such as administration of antenatal steroids, intrapartum magnesium for preterm delivery, and therapeutic hypothermia. In addition, we examine emerging practices such as delayed cord clamping, postnatal magnesium administration, recombinant erythropoietin, and non-steroidal anti-inflammatory agents and finally inform the reader about novel interventions, some of which are currently in trials, such as xenon, melatonin, topiramate, allopurinol, creatine, and autologous cord cell therapy. F1000 Research Limited 2019-11-29 /pmc/articles/PMC6979470/ /pubmed/32047595 http://dx.doi.org/10.12688/f1000research.20722.1 Text en Copyright: © 2019 Singhi S and Johnston M http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Singhi, Samata
Johnston, Michael
Recent advances in perinatal neuroprotection
title Recent advances in perinatal neuroprotection
title_full Recent advances in perinatal neuroprotection
title_fullStr Recent advances in perinatal neuroprotection
title_full_unstemmed Recent advances in perinatal neuroprotection
title_short Recent advances in perinatal neuroprotection
title_sort recent advances in perinatal neuroprotection
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979470/
https://www.ncbi.nlm.nih.gov/pubmed/32047595
http://dx.doi.org/10.12688/f1000research.20722.1
work_keys_str_mv AT singhisamata recentadvancesinperinatalneuroprotection
AT johnstonmichael recentadvancesinperinatalneuroprotection